Nanoparticles Help to Enhance Lung Cancer PD-L1 Inhibitors :

A nanoparticle-based immunotherapy, called ARAC (Antigen Release Agent and Checkpoint Inhibitor) enhanced the efficacy of PD-L1 inhibitors against lung cancer.

Related Keywords

Julia Lazebnaya Shutterstock , Development Of Immunotherapy , Nature Communications , Enhance Lung Cancer , Antigen Release Agent , Checkpoint Inhibitor , Checkpoint Inhibitors , Lung Cancer , Lung Cancer Treatment ,